Business · 05/06/1997Updated: 10/17/2026 · 1 min read
FDA Announces Meetings of Oversight Committee to Review Clinical Hold Orders for Investigational Biological Products
Summary
The FDA is inviting biological product companies to submit confidential reviews of investigational biological product trials placed on clinical hold over the past year to its oversight committee
Original source language: Federal Register — Food and Drug AdministrationOpen original release →